# Donnelley Financial Solutions, Inc.: financial statements, quarterly

DFIN · NYSE · CIK 1669811 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dfin.md) · [Financials](/companies/dfin/financials.md) · [Filings](/companies/dfin/filings.md) · [Insiders](/companies/dfin/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dfin/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [180](/filings/0000950170-24-119519.md) | [177 d](/filings/0001193125-26-054586.md) | [203](/filings/0000950170-25-061031.md) | [243](/filings/0000950170-25-100884.md) | [180](/filings/0001193125-25-256296.md) | [156 d](/filings/0001193125-26-054586.md) | [201](/filings/0001193125-26-206350.md) | [218](/filings/0001193125-26-326099.md) | [175](/filings/0001193125-25-256296.md) | [173 d](/filings/0001193125-26-054586.md) | [206](/filings/0001193125-26-206350.md) | [224](/filings/0001193125-26-326099.md) |
| Selling, general and administrative | $m | [65.4](/filings/0000950170-24-119519.md) | [70.0 d](/filings/0001193125-26-054586.md) | [72.8](/filings/0000950170-25-061031.md) | [76.1](/filings/0000950170-25-100884.md) | [74.0](/filings/0001193125-25-256296.md) | [68.0 d](/filings/0001193125-26-054586.md) | [65.8](/filings/0001193125-26-206350.md) | [70.0](/filings/0001193125-26-326099.md) | [67.3](/filings/0001193125-25-256296.md) | [74.8 d](/filings/0001193125-26-054586.md) | [67.4](/filings/0001193125-26-206350.md) | [74.7](/filings/0001193125-26-326099.md) |
| Operating income | $m | [29.8](/filings/0000950170-24-119519.md) | [9.8 d](/filings/0001193125-26-054586.md) | [44.6](/filings/0000950170-25-061031.md) | [64.5](/filings/0000950170-25-100884.md) | [18.2](/filings/0001193125-25-256296.md) | [9.3 d](/filings/0001193125-26-054586.md) | [45.8](/filings/0001193125-26-206350.md) | [52.8](/filings/0001193125-26-326099.md) | [28.2](/filings/0001193125-25-256296.md) | [14.3 d](/filings/0001193125-26-054586.md) | [48.5](/filings/0001193125-26-206350.md) | [56.0](/filings/0001193125-26-326099.md) |
| Interest expense | $m | [4.1](/filings/0000950170-24-119519.md) | [3.6 d](/filings/0001193125-26-054586.md) | [3.6](/filings/0000950170-25-061031.md) | [3.7](/filings/0000950170-25-100884.md) | [3.1](/filings/0001193125-25-256296.md) | [2.5 d](/filings/0001193125-26-054586.md) | [3.1](/filings/0001193125-26-206350.md) | [3.8](/filings/0001193125-26-326099.md) | [2.9](/filings/0001193125-25-256296.md) | [3.1 d](/filings/0001193125-26-054586.md) | [2.8](/filings/0001193125-26-206350.md) | [3.5](/filings/0001193125-26-326099.md) |
| Income tax | $m | [7.7](/filings/0000950170-24-119519.md) | [(3.9) d](/filings/0001193125-26-054586.md) | [8.1](/filings/0000950170-25-061031.md) | [17.1](/filings/0000950170-25-100884.md) | [6.7](/filings/0001193125-25-256296.md) | [0.8 d](/filings/0001193125-26-054586.md) | [11.2](/filings/0001193125-26-206350.md) | [12.6](/filings/0001193125-26-326099.md) | [(17.0)](/filings/0001193125-25-256296.md) | [3.9 d](/filings/0001193125-26-054586.md) | [11.9](/filings/0001193125-26-206350.md) | [15.7](/filings/0001193125-26-326099.md) |
| Net income | $m | [18.1](/filings/0000950170-24-119519.md) | [10.6 d](/filings/0001193125-26-054586.md) | [33.3](/filings/0000950170-25-061031.md) | [44.1](/filings/0000950170-25-100884.md) | [8.7](/filings/0001193125-25-256296.md) | [6.3 d](/filings/0001193125-26-054586.md) | [31.0](/filings/0001193125-26-206350.md) | [36.1](/filings/0001193125-26-326099.md) | [(40.9)](/filings/0001193125-25-256296.md) | [6.2 d](/filings/0001193125-26-054586.md) | [33.5](/filings/0001193125-26-206350.md) | [36.4](/filings/0001193125-26-326099.md) |
| Diluted EPS | $ per share | [0.60](/filings/0000950170-24-119519.md) | not reported | [1.09](/filings/0000950170-25-061031.md) | [1.47](/filings/0000950170-25-100884.md) | [0.29](/filings/0001193125-25-256296.md) | not reported | [1.05](/filings/0001193125-26-206350.md) | [1.28](/filings/0001193125-26-326099.md) | [(1.49)](/filings/0001193125-25-256296.md) | not reported | [1.27](/filings/0001193125-26-206350.md) | [1.44](/filings/0001193125-26-326099.md) |
| Basic EPS | $ per share | [0.62](/filings/0000950170-24-119519.md) | not reported | [1.14](/filings/0000950170-25-061031.md) | [1.50](/filings/0000950170-25-100884.md) | [0.30](/filings/0001193125-25-256296.md) | not reported | [1.08](/filings/0001193125-26-206350.md) | [1.30](/filings/0001193125-26-326099.md) | [(1.49)](/filings/0001193125-25-256296.md) | not reported | [1.30](/filings/0001193125-26-206350.md) | [1.45](/filings/0001193125-26-326099.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.7](/filings/0000950170-23-057425.md) | [23.1](/filings/0000950170-25-022207.md) | [43.7](/filings/0000950170-24-051247.md) | [35.0](/filings/0000950170-24-088551.md) | [33.6](/filings/0000950170-24-119519.md) | [57.3](/filings/0001193125-26-054586.md) | [16.2](/filings/0000950170-25-061031.md) | [33.8](/filings/0000950170-25-100884.md) | [22.7](/filings/0001193125-25-256296.md) | [24.5](/filings/0001193125-26-326099.md) | [26.1](/filings/0001193125-26-206350.md) | [25.3](/filings/0001193125-26-326099.md) |
| Current assets | $m | [230](/filings/0000950170-23-057425.md) | [209](/filings/0000950170-25-022207.md) | [268](/filings/0000950170-24-051247.md) | [279](/filings/0000950170-24-088551.md) | [237](/filings/0000950170-24-119519.md) | [233](/filings/0001193125-26-054586.md) | [243](/filings/0000950170-25-061031.md) | [267](/filings/0000950170-25-100884.md) | [218](/filings/0001193125-25-256296.md) | [211](/filings/0001193125-26-326099.md) | [261](/filings/0001193125-26-206350.md) | [255](/filings/0001193125-26-326099.md) |
| Total assets | $m | [839](/filings/0000950170-24-119519.md) | [807](/filings/0000950170-25-022207.md) | [868](/filings/0000950170-24-051247.md) | [883](/filings/0000950170-24-088551.md) | [844](/filings/0000950170-24-119519.md) | [842](/filings/0001193125-26-054586.md) | [853](/filings/0000950170-25-061031.md) | [875](/filings/0000950170-25-100884.md) | [816](/filings/0001193125-25-256296.md) | [800](/filings/0001193125-26-326099.md) | [841](/filings/0001193125-26-206350.md) | [834](/filings/0001193125-26-326099.md) |
| Current liabilities | $m | [197](/filings/0000950170-23-057425.md) | [202](/filings/0000950170-25-022207.md) | [180](/filings/0000950170-24-051247.md) | [193](/filings/0000950170-24-088551.md) | [207](/filings/0000950170-24-119519.md) | [224](/filings/0001193125-26-054586.md) | [196](/filings/0000950170-25-061031.md) | [207](/filings/0000950170-25-100884.md) | [193](/filings/0001193125-25-256296.md) | [200](/filings/0001193125-26-326099.md) | [186](/filings/0001193125-26-206350.md) | [193](/filings/0001193125-26-326099.md) |
| Total liabilities | $m | [454](/filings/0000950170-23-057425.md) | [405](/filings/0000950170-25-022207.md) | [459](/filings/0000950170-24-051247.md) | [441](/filings/0000950170-24-088551.md) | [399](/filings/0000950170-24-119519.md) | [406](/filings/0001193125-26-054586.md) | [433](/filings/0000950170-25-061031.md) | [443](/filings/0000950170-25-100884.md) | [393](/filings/0001193125-25-256296.md) | [421](/filings/0001193125-26-326099.md) | [464](/filings/0001193125-26-206350.md) | [447](/filings/0001193125-26-326099.md) |
| Long-term debt | $m | [166](/filings/0000950170-23-057425.md) | [125](/filings/0000950170-25-022207.md) | [205](/filings/0000950170-24-051247.md) | [180](/filings/0000950170-24-088551.md) | [125](/filings/0000950170-24-119519.md) | [125](/filings/0001193125-26-054586.md) | [184](/filings/0000950170-25-061031.md) | [184](/filings/0000950170-25-100884.md) | [149](/filings/0001193125-25-256296.md) | [166](/filings/0001193125-26-326099.md) | [224](/filings/0001193125-26-206350.md) | [198](/filings/0001193125-26-326099.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-054586.md) | [5.8](/filings/0000950170-25-061031.md) | [5.8](/filings/0000950170-25-100884.md) | [5.8](/filings/0001193125-25-256296.md) | [5.8](/filings/0001193125-26-326099.md) | [5.8](/filings/0001193125-26-206350.md) | [5.8](/filings/0001193125-26-326099.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [385](/filings/0000950170-24-119519.md) | [402](/filings/0001193125-26-054586.md) | [409](/filings/0000950170-25-100884.md) | [442](/filings/0001193125-25-256296.md) | [445](/filings/0001193125-25-256296.md) | [436](/filings/0001193125-26-326099.md) | [420](/filings/0001193125-26-326099.md) | [432](/filings/0001193125-26-326099.md) | [423](/filings/0001193125-25-256296.md) | [379](/filings/0001193125-26-326099.md) | [377](/filings/0001193125-26-326099.md) | [387](/filings/0001193125-26-326099.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [80.5 d](/filings/0000950170-24-119519.md) | [74.8 d](/filings/0001193125-26-054586.md) | [(27.9)](/filings/0000950170-25-061031.md) | [56.2 d](/filings/0000950170-25-100884.md) | [86.4 d](/filings/0001193125-25-256296.md) | [56.4 d](/filings/0001193125-26-054586.md) | [(37.7)](/filings/0001193125-26-206350.md) | [68.4 d](/filings/0001193125-26-326099.md) | [74.4 d](/filings/0001193125-25-256296.md) | [59.8 d](/filings/0001193125-26-054586.md) | [(5.6)](/filings/0001193125-26-206350.md) | [74.7 d](/filings/0001193125-26-326099.md) |
| Capital expenditure | $m | [19.2](/filings/0000950170-23-057425.md) | [18.8 d](/filings/0001193125-26-054586.md) | [12.3](/filings/0000950170-25-061031.md) | [19.4 d](/filings/0000950170-25-100884.md) | [19.1 d](/filings/0001193125-25-256296.md) | [15.1 d](/filings/0001193125-26-054586.md) | [13.3](/filings/0001193125-26-206350.md) | [16.7 d](/filings/0001193125-26-326099.md) | [15.2 d](/filings/0001193125-25-256296.md) | [11.9 d](/filings/0001193125-26-054586.md) | [10.4](/filings/0001193125-26-206350.md) | [13.5 d](/filings/0001193125-26-326099.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [14.8 d](/filings/0000950170-24-119519.md) | [4.9 d](/filings/0001193125-26-054586.md) | [30.8](/filings/0000950170-25-061031.md) | [19.9 d](/filings/0000950170-25-100884.md) | [13.7 d](/filings/0001193125-25-256296.md) | [17.2 d](/filings/0001193125-26-054586.md) | [53.0](/filings/0001193125-26-206350.md) | [35.7 d](/filings/0001193125-26-326099.md) | [34.4 d](/filings/0001193125-25-256296.md) | [61.9 d](/filings/0001193125-26-054586.md) | [40.9](/filings/0001193125-26-206350.md) | [35.3 d](/filings/0001193125-26-326099.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [30.9](/filings/0000950170-23-057425.md) | [30.5](/filings/0000950170-24-051247.md) | [30.4](/filings/0000950170-24-088551.md) | [30.3](/filings/0000950170-24-119519.md) | [30.5](/filings/0000950170-25-061031.md) | [30.0](/filings/0000950170-25-100884.md) | [29.9](/filings/0001193125-25-256296.md) | [29.5](/filings/0001193125-26-206350.md) | [28.2](/filings/0001193125-26-326099.md) | [27.4](/filings/0001193125-25-256296.md) | [26.3](/filings/0001193125-26-206350.md) | [25.3](/filings/0001193125-26-326099.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,585,383 at 2026-07-24, from the cover of the [10-Q filed 2026-07-30](/filings/0001193125-26-326099.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.